Parental preferences for treatment: Preliminary report from a randomised comparison of treatment strategies in (early) juvenile idiopathic arthritis (BeSt for Kids trial)

por Muller, PCE Hissink, Brederije, I, Brinkman DMC, DMC, Allaart, CF, van Suijlekom-Smit, LWA, van Rossum, MAJ, ten Cate, R
Publicado 2011

Development of a web-based register for the Dutch national study on biologicals in juvenile idiopathic arthritis: http://www.abc-register.nl

por Prince, FHM, Ferket, IS, Kamphuis, SSM, Armbrust, W, Ten Cate, R, Hoppenreijs, EPAH, Koopman-Keemink, Y, van Rossum, MAJ, van Santen-Hoeufft, M, Twilt, M, van Suijlekom-Smit, LWA
Publicado 2008

Time to treatment as an important factor for the response to methotrexate in juvenile idiopathic arthritis

por Albers, HM, Wessels, JAM, Straaten, RJH van der, Brinkman, DMC, Suijlekom-Smit, LWA, Kamphuis, SSM, Girschick, HJ, Wouters, C, Schilham, MW, le Cessie, S, Huizinga, TWJ, ten Cate, R, Guchelaar, HJ
Publicado 2008

When and how to stop etanercept after successful treatment of patients with juvenile idiopathic arthritis

por Prince, FHM, Twilt, M, Simon, SCM, van Rossum, MAJ, Armbrust, W, Hoppenreijs, EPAH, Kamphuis, SSM, van Santen-Hoeufft, M, Koopman-Keemink, Y, Wulffraat, N, ten Cate, R, van Suijlekom-Smit, LWA
Publicado 2008

Etanercept in juvenile idiopathic arthritis: Who will benefit?

por Otten, MH, Prince, FHM, Armbrust, W, ten Cate, R, Hoppenreijs, EPAH, Twilt, M, Koopman-Keemink, Y, Gorter, SL, Dolman, KM, Swart, JF, van den Berg, JM, Wulffraat, NM, van Rossum, MAJ, van Suijlekom-Smit, LWA
Publicado 2011